Tebentafusp as a Promising Drug for the Treatment of Uveal Melanoma

• Published in: Current drug targets Vol. 25; no. 3; p. 149
• Main Authors: Al Balushi, Khalid, Al Hadhrami, Abdulrahman, Balushi, Hamdan Al, Al Lawati, Abdullah, Das, Srijit
• Format: Journal Article
• Language: English
• Published: United Arab Emirates 01.01.2024
• Subjects: Antineoplastic Agents - pharmacology; Antineoplastic Agents - therapeutic use; Clinical Trials as Topic; Humans; Melanoma - drug therapy; Melanoma - pathology; Uveal Neoplasms - drug therapy; treatment; tumor; Uveal melanoma; tebentafusp; malignant; drug; etiology

Uveal melanoma (UM) is the most common primary intraocular malignancy in adults and commonly occurs in the Caucasian population. The malignancy involves the uvea of the eye, which includes the iris, ciliary body, and choroid. The etiology of UM is still not well understood, but age is a risk factor....